Robert Langer, 10% Owner at INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV), sold 190,735 shares at $2.46 ($470K) on 2013-01-16, disclosed to the SEC on 2013-01-17.
Open-market sale of $470k NVIV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.47 | 35,436 | $88K | 18.6% |
| 2 | $2.46 | 102,874 | $253K | 53.9% |
| 3 | $2.46 | 52,425 | $129K | 27.5% |
| Total | $2.46 avg | 190,735 | $470K | 100% |
| Filing → |
| RUBY | SELL | 2019-04-17 | $132K | — | Filing → |
| RUBY | SELL | 2019-01-18 | $109K | — | Filing → |
| NVIV | SELL | 2013-06-05 | $28K | — | Filing → |